The Studies · fact-check
Does hyperbaric oxygen reverse aging? What the telomere study actually showed
Hyperbaric oxygen therapy “reverses aging” by lengthening telomeres and clearing senescent cells.
A real, peer-reviewed signal – at a clinical dose you cannot buy, in a tiny sample with no control arm for the telomere result, from a team that sells the treatment. Intriguing, not settled, and not what a home chamber delivers.
What it actually found
Thirty-five healthy adults over 64 did 60 hyperbaric sessions over three months at 2.0 ATA breathing pure oxygen. Telomere length in isolated immune cells rose by up to ~38% (in B cells), and senescent-cell counts fell by up to ~37%. A separate randomised arm of 63 people found improvements in attention and processing speed that tracked with cerebral blood flow.
On its face that is a striking result, and it is the single paper behind almost every "hyperbaric reverses aging" headline you have seen.
The caveats the headlines skip
The telomere result had no control group – it is a single-arm before-and-after in 35 people, the weakest design for a claim this big. The cognition arm was properly randomised, but still small, short, and single-centre.
The lead author chairs the medical advisory board of, and holds shares in, the clinic that sells the treatment. That does not make the data wrong, but independent replication is thin, and a financial interest in the result is a reason for caution, not excitement.
Durability is unknown: no source establishes how long any effect lasts after the sessions stop.
What it means if you are buying a chamber
The dose that produced these numbers was 2.0 ATA on 100% oxygen, supervised, for 60 sessions. The soft-shell chambers sold for home use cap at 1.3 ATA on room air – a different, weaker intervention that this study did not test. Citing the 2.0 ATA telomere result to sell a 1.3 ATA home unit is the category’s central bait-and-switch.
If the science interests you, buy a course of clinic sessions at the studied dose, not a five-figure home chamber that cannot reach it. See our scored hyperbaric guide for the rent-versus-buy math.
What we read
- Aging · Efrati et al. (2020)Telomere lengthening at 2.0 ATA across 60 sessions →
- Aging · Efrati et al. (2020)Cognition RCT in healthy adults 64+ →
- Popular ScienceSkeptical coverage and the conflict of interest →
- FDAHBOT is not cleared for anti-aging (2025 guidance) →
See the scored Hyperbaric chambers guide →
By David Persson · Updated 2026-06-12 · Corrections: hi@agewell.guide